drugset / Trial / NCT01927731
Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This phase II trial studies how well eltrombopag olamine works in increasing platelet counts in patients undergoing transplant. Eltrombopag olamine may help platelet counts and the immune system recover from blood or bone marrow transplant.
Timeline
- Start
- 2013-10-14
- Primary completion
- 2023-06-06
- Completion
- 2023-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eltrombopag | Small molecule | — | Oral |